D.E. Shaw & Co’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
Sell
-30
Closed -$276K 4286
2021
Q3
$276K Buy
30
+6
+25% +$55.2K ﹤0.01% 3105
2021
Q2
$247K Buy
+24
New +$247K ﹤0.01% 3171